David Toung
Stock Analyst at Argus Research
(4.40)
# 321
Out of 4,754 analysts
117
Total ratings
67.03%
Success rate
11.35%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELV Elevance Health | Reiterates: Hold | $405 | $395.50 | +2.50% | 1 | Jan 29, 2025 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $211.48 | - | 6 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $115 → $125 | $129.18 | -3.24% | 9 | Sep 11, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $570 → $600 | $467.05 | +28.47% | 7 | Jul 17, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Hold | n/a | $163.51 | - | 5 | Jun 28, 2024 | |
| AMGN Amgen | Maintains: Buy | $300 → $340 | $310.78 | +9.40% | 10 | Jun 27, 2024 | |
| MCK McKesson | Maintains: Buy | $570 → $670 | $644.53 | +3.95% | 6 | Jun 24, 2024 | |
| ZBH Zimmer Biomet Holdings | Upgrades: Buy | $150 | $105.38 | +42.34% | 7 | May 21, 2024 | |
| LLY Eli Lilly and Company | Maintains: Buy | $770 → $840 | $929.72 | -9.65% | 3 | May 14, 2024 | |
| HOLX Hologic | Maintains: Buy | $89 → $95 | $63.24 | +50.22% | 1 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $86.45 | +27.24% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $253.84 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $26.25 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $261.54 | - | 8 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $540 → $550 | $523.64 | +5.03% | 6 | Nov 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $22.45 | - | 1 | Jun 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $394.88 | -21.50% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $311.28 | -0.41% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $566.98 | -43.56% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $140.22 | -3.72% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $115.99 | -35.34% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $59.88 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $93.15 | +18.09% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $94.30 | +74.97% | 6 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $9.43 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $123 | $61.19 | +100.20% | 3 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $76.10 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $110.62 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $167.28 | -7.34% | 4 | Mar 27, 2020 |
Elevance Health
Jan 29, 2025
Reiterates: Hold
Price Target: $405
Current: $395.50
Upside: +2.50%
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $211.48
Upside: -
Cardinal Health
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $129.18
Upside: -3.24%
UnitedHealth Group
Jul 17, 2024
Maintains: Buy
Price Target: $570 → $600
Current: $467.05
Upside: +28.47%
Charles River Laboratories International
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $163.51
Upside: -
Amgen
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $310.78
Upside: +9.40%
McKesson
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $644.53
Upside: +3.95%
Zimmer Biomet Holdings
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $105.38
Upside: +42.34%
Eli Lilly and Company
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $929.72
Upside: -9.65%
Hologic
May 9, 2024
Maintains: Buy
Price Target: $89 → $95
Current: $63.24
Upside: +50.22%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $86.45
Upside: +27.24%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $253.84
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $26.25
Upside: -
Mar 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $261.54
Upside: -
Nov 6, 2023
Maintains: Buy
Price Target: $540 → $550
Current: $523.64
Upside: +5.03%
Jun 8, 2023
Downgrades: Hold
Price Target: n/a
Current: $22.45
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $394.88
Upside: -21.50%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $311.28
Upside: -0.41%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $566.98
Upside: -43.56%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $140.22
Upside: -3.72%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $115.99
Upside: -35.34%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $59.88
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $93.15
Upside: +18.09%
Aug 27, 2021
Maintains: Buy
Price Target: $150 → $165
Current: $94.30
Upside: +74.97%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $9.43
Upside: -
Jun 18, 2021
Maintains: Buy
Price Target: $110 → $123
Current: $61.19
Upside: +100.20%
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $76.10
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $110.62
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $167.28
Upside: -7.34%